After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

A multi-strain probiotic blend shows promise for protecting brain function by reducing gut-triggered inflammation linked to ...

What if you could detect Alzheimer's before symptoms even start? Researchers are racing against the clock to find a way. A ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...